These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25245620)

  • 1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels.
    Hanberger H; Antonelli M; Holmbom M; Lipman J; Pickkers P; Leone M; Rello J; Sakr Y; Walther SM; Vanhems P; Vincent JL;
    BMC Infect Dis; 2014 Sep; 14():513. PubMed ID: 25245620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome.
    De Waele J; Lipman J; Sakr Y; Marshall JC; Vanhems P; Barrera Groba C; Leone M; Vincent JL;
    BMC Infect Dis; 2014 Jul; 14():420. PubMed ID: 25074742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate.
    Lupei MI; Mann HJ; Beilman GJ; Oancea C; Chipman JG
    Surg Infect (Larchmt); 2010 Feb; 11(1):33-9. PubMed ID: 19785562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial.
    Oostdijk EAN; Kesecioglu J; Schultz MJ; Visser CE; de Jonge E; van Essen EHR; Bernards AT; Purmer I; Brimicombe R; Bergmans D; van Tiel F; Bosch FH; Mascini E; van Griethuysen A; Bindels A; Jansz A; van Steveninck FAL; van der Zwet WC; Fijen JW; Thijsen S; de Jong R; Oudbier J; Raben A; van der Vorm E; Koeman M; Rothbarth P; Rijkeboer A; Gruteke P; Hart-Sweet H; Peerbooms P; Winsser LJ; van Elsacker-Niele AW; Demmendaal K; Brandenburg A; de Smet AMGA; Bonten MJM
    JAMA; 2014 Oct; 312(14):1429-1437. PubMed ID: 25271544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
    Vincent JL; Bihari DJ; Suter PM; Bruining HA; White J; Nicolas-Chanoin MH; Wolff M; Spencer RC; Hemmer M
    JAMA; 1995 Aug 23-30; 274(8):639-44. PubMed ID: 7637145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bacterial resistance on mortality in intensive care units: a registry study from 2000 to 2013 (IICU Study).
    Bonnet V; Dupont H; Glorion S; Aupée M; Kipnis E; Gérard JL; Hanouz JL; Fischer MO
    J Hosp Infect; 2019 Jul; 102(3):317-324. PubMed ID: 30659869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.
    Hanberger H; Walther S; Leone M; Barie PS; Rello J; Lipman J; Marshall JC; Anzueto A; Sakr Y; Pickkers P; Felleiter P; Engoren M; Vincent JL;
    Int J Antimicrob Agents; 2011 Oct; 38(4):331-5. PubMed ID: 21798720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study.
    Agaba P; Tumukunde J; Tindimwebwa JVB; Kwizera A
    BMC Res Notes; 2017 Jul; 10(1):349. PubMed ID: 28754148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European intensive care physicians' experience of infections due to antibiotic-resistant bacteria.
    Lepape A; Jean A; De Waele J; Friggeri A; Savey A; Vanhems P; Gustin MP; Monnet DL; Garnacho-Montero J; Kohlenberg A
    Antimicrob Resist Infect Control; 2020; 9(1):1. PubMed ID: 31908772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial.
    van Duijn PJ; Verbrugghe W; Jorens PG; Spöhr F; Schedler D; Deja M; Rothbart A; Annane D; Lawrence C; Nguyen Van JC; Misset B; Jereb M; Seme K; Šifrer F; Tomiç V; Estevez F; Carneiro J; Harbarth S; Eijkemans MJC; Bonten M;
    Lancet Infect Dis; 2018 Apr; 18(4):401-409. PubMed ID: 29396000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal.
    Serra-Burriel M; Campillo-Artero C; Agodi A; Barchitta M; López-Casasnovas G
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1360-1367. PubMed ID: 34657648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial.
    van Duijn PJ; Bonten MJ
    Trials; 2014 Jul; 15():277. PubMed ID: 25011604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differences in the use of tigecycline between ICU patients and non-ICU patients].
    Alvarez-Lerma F; Blanco L; Rodríguez JA; Grau S; Conde-Estévez D; Luque S
    Rev Esp Quimioter; 2010 Jun; 23(2):63-71. PubMed ID: 20559603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality.
    Maseda E; Ramírez S; Picatto P; Peláez-Peláez E; García-Bernedo C; Ojeda-Betancur N; Aguilar G; Forés B; Solera-Marín J; Aliaño-Piña M; Tamayo E; Ramasco F; García-Álvarez R; González-Lisorge A; Giménez MJ; Suárez-de-la-Rica A;
    PLoS One; 2019; 14(9):e0223092. PubMed ID: 31557256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units.
    Walther SM; Erlandsson M; Burman LG; Cars O; Gill H; Hoffman M; Isaksson B; Kahlmeter G; Lindgren S; Nilsson L; Olsson-Liljequist B; Hanberger H;
    Acta Anaesthesiol Scand; 2002 Oct; 46(9):1075-81. PubMed ID: 12366501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
    Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
    Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.